News Formal

Drug firm Lilly makes largest investment in its home state

  • 📰 DCN_Canada
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 74%

Business News News

Business Business Latest News,Business Business Headlines

Canada's construction news

Indiana-based Eli Lilly is making the single biggest U.S. investment in synthetic medicine manufacturing at a new state business park in Lebanon, Ind.

The campus will comprise 600 acres and begin production in 2026, “scaling up” through 2028, according to a company release. The corporation declined further comment. The investment will expand Lilly’s ability to manufacture active pharmaceutical ingredients for Zepbound injection and Mounjaro injection. These drugs are for adults with chronic diseases like obesity and Type 2 diabetes.Not only is this the largest investment in synthetic drug manufacturing but it’s Lilly’s largest investment ever.

Indiana Gov. Eric Holcomb said the state attributes the investment to its “leadership” in developing sites like the LEAP Research and Innovation District.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 17. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly's new Alzheimer's treatment could 'lift' drug marketEli Lilly (LLY) is one step closer to getting its new Alzheimer's treatment approved by the Food and Drug Administration (FDA) after a panel voted to...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »